Search results for "Statins"


 
Results 71 - 80 of about 245 for "Statins".
Sort by: Relevance | Newest | Oldest

Some antibiotics taken with statins by older patients may cause more hospitalizations, all-cause mortality

Older people taking statins who were prescribed clarithromycin or erythromycin were hospitalized more frequently for rhabdomyolysis and acute kidney injury and had higher all-cause mortality than people who were prescribed azithromycin, a Canadian study found.
https://immattersacp.org/weekly/archives/2013/06/18/1.htm
18 Jun 2013

Lower-dose statins plus combination therapies may be an alternative for patients intolerant of or unresponsive to high-dose statins

Clinicians could cautiously consider using a lower-intensity statin combined with a bile acid sequestrant or ezetimibe for high-risk patients intolerant of or unresponsive to statins, a meta-analysis found.
https://immattersacp.org/weekly/archives/2014/02/11/1.htm
11 Feb 2014

Side effects rare with statins, two types may have best safety profiles

Side effects associated with statin therapy are not common, and simvastatin and pravastatin may be safer and more tolerable than other drugs in the class, reported a meta-analysis that totaled nearly a quarter-million people.
https://immattersacp.org/weekly/archives/2013/07/16/1.htm
16 Jul 2013

Watch out for NAFLD, treat ASAP

While nonalcoholic fatty liver disease and nonalcoholic steatohepatitis are dynamic processes that can progress and regress, lifestyle modification, including diet, is a must for all patients, wherever they are in their disease.
https://immattersacp.org/archives/2021/04/watch-out-for-nafld-treat-asap.htm
1 Apr 2021

Intensive-dose statins don't confer greater diabetes risk for post-MI elderly than moderate doses

Older patients with myocardial infarction (MI) who take intensive-dose statins have the same risk of developing diabetes as those who take moderate-dose statins, a new study found.
https://immattersacp.org/weekly/archives/2013/05/21/5.htm
21 May 2013

Anti-inflammatory agents may effectively, safely curb major depressive symptoms, study finds

A pooled data analysis looked at depression treatment trials that compared NSAIDs, omega-3 fatty acids, cytokine inhibitors, statins, steroids, minocycline, modafinil, or N-acetylcysteine to placebo.
https://immattersacp.org/weekly/archives/2019/11/05/4.htm
5 Nov 2019

Model may predict which coronary artery disease patients benefit from high-dose statins

Incremental treatment effects of high-dose statin therapy over usual-dose statin therapy in coronary artery disease patients can be estimated by a prediction model made up of 13 easy-to-measure clinical predictors that are readily available in clinical practice, a study concluded.
https://immattersacp.org/weekly/archives/2013/05/21/4.htm
21 May 2013

Statins' benefits outweigh their association with diabetes incidence

Statins' benefits outweigh the risk of diabetes for patients taking the drugs for secondary prevention and those at high risk of major adverse coronary events, a study found.
https://immattersacp.org/weekly/archives/2012/08/14/4.htm
14 Aug 2012

Non-HDL cholesterol may be best marker of cardiovascular risk in statin-treated patients

Non-high-density lipoprotein cholesterol may be a better marker of cardiovascular risk in patients taking statins than low-density lipoprotein cholesterol or apolipoprotein B, according to a new study.
https://immattersacp.org/weekly/archives/2012/04/03/4.htm
3 Apr 2012

Diabetes risk from statins may be offset by reduction in cardiovascular events

Atorvastatin, 80 mg/d, carries a higher risk of developing diabetes than do lower doses, but only among patients who already have multiple risk factors, a study found.
https://immattersacp.org/weekly/archives/2012/12/18/1.htm
18 Dec 2012

Result Page: Prev   3   4   5   6   7   8   9   10   11   12   Next